InsidersTradesSigma
Follow the 툴젠 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 툴젠 has published 8 public disclosures. Market capitalisation: €354.4bn. The latest transaction was filed on 1 September 2026 (Purchase). Among the most active insiders: 제넥신. All data is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
툴젠 is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing genome editing technologies.